BioCryst Pharmaceuticals, Inc.
BCRX
$10.34
$0.505.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.59% | -19.21% | -14.37% | -35.50% | -4.41% |
| Total Receivables | 21.47% | 17.00% | 35.09% | 26.04% | 32.60% |
| Inventory | 20.06% | -12.92% | -33.25% | -30.81% | 13.35% |
| Prepaid Expenses | 18.16% | 33.41% | 24.94% | 1.36% | -23.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -98.39% | 193.47% | -4.29% | 3,559.53% | 1,552.48% |
| Total Current Assets | 21.64% | -8.87% | -4.18% | -16.73% | 9.63% |
|
|
|||||
| Total Current Assets | 21.64% | -8.87% | -4.18% | -16.73% | 9.63% |
| Net Property, Plant & Equipment | 8.31% | 17.42% | -4.04% | -2.01% | 0.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 79.94% | 59.86% | 4.65% | 26.97% | 15.44% |
| Total Assets | 22.02% | -3.12% | 4.84% | -9.13% | -3.22% |
|
|
|||||
| Total Accounts Payable | 33.41% | 9.05% | 35.92% | -58.71% | 10.31% |
| Total Accrued Expenses | 13.80% | 28.89% | 11.58% | 13.99% | 19.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.01% | 16.78% | 13.08% | 9.98% | 19.15% |
| Total Finance Division Other Current Liabilities | 20.97% | -- | -- | -- | -- |
| Total Other Current Liabilities | 20.97% | -- | -- | -- | -- |
| Total Current Liabilities | 17.89% | 39.71% | 22.25% | 23.88% | 37.26% |
|
|
|||||
| Total Current Liabilities | 17.89% | 39.71% | 22.25% | 23.88% | 37.26% |
| Long-Term Debt | 12.70% | 2.60% | -46.32% | -20.43% | -14.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.74% | 21.82% | -0.36% | 0.25% | 0.51% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2,864.98% | -- | -- | -- | -- |
| Total Liabilities | 15.18% | 9.33% | -34.46% | -13.08% | -7.30% |
|
|
|||||
| Common Stock & APIC | 26.40% | 27.15% | 7.25% | 7.12% | 7.07% |
| Retained Earnings | -21.80% | -25.87% | 14.91% | -0.50% | -2.07% |
| Treasury Stock & Other | -132.08% | -132.51% | -95.87% | -50.28% | 195.51% |
| Total Common Equity | -7.76% | -22.55% | 74.96% | 17.22% | 11.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.76% | -22.55% | 74.96% | 17.22% | 11.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.76% | -22.55% | 74.96% | 17.22% | 11.36% |
|
|
|||||